StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$8.30M. The highest annual figure on record is -$2.86M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.30M–
FY2024Dec 31, 2024-$7.20M–
FY2023Dec 31, 2023-$3.33M–
FY2022Dec 31, 2022-$16.50M–
FY2021Dec 31, 2021-$11.95M–
FY2020Dec 31, 2020-$2.86M–
FY2019Dec 31, 2019-$5.45M–
FY2018Dec 31, 2018-$5.15M–

More NewcelX figures

See a number that looks wrong?